Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Y. A. Chabbert"'
Publikováno v:
Ciba Foundation Symposium-Bacterial Episomes and Plasmids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e941851399d2c456f34fc074a3b0fc7e
https://doi.org/10.1002/9780470715345.ch14
https://doi.org/10.1002/9780470715345.ch14
Publikováno v:
Frontiers in Cellular & Infection Microbiology; 2024, p1-16, 16p
Autor:
Y. A. Chabbert, A. Roussel
Publikováno v:
Journal of Antimicrobial Chemotherapy. 3:25-33
Publikováno v:
Antimicrobial Agents and Chemotherapy. 23:622-625
beta-Lactam-resistant mutants of Escherichia coli K-12 were selected by using 12 different beta-lactam derivatives. The mutants fell into three categories showing (i) altered permeation through reduction or loss of outer membrane porin proteins (incl
Autor:
Y. A. Chabbert, E. Derlot
Publikováno v:
Journal of Antimicrobial Chemotherapy. 11:159-167
The antibacterial activity of cefotetan, a new cephamycin, was compared with that of cephalothin, cefoxitin, cefamandole, cefoperazone and cefotaxime on 12 substrains of Escherichia coli K12 BM13 harbouring single and multi-copy plasmids coding for p
Publikováno v:
Journal of Infectious Diseases. 124:247-254
Defective strains of Streptococcus were isolated from cardiac valves or blood cultures from three patients with bacterial endocarditis. These strains did not grow on the usual media under aerobic or anaerobic conditions. Enrichment of media with L-cy
Autor:
D. H. Bouanchaud, Y. A. Chabbert
Publikováno v:
Annals of the New York Academy of Sciences. 182:305-311
Autor:
D. H. Bouanchaud, Y. A. Chabbert
Publikováno v:
Journal of General Microbiology. 58:107-113
SUMMARY During an epidemic, a strain of Salmonella panama resistant to ampicillin, kanamycin, tetracycline and which was colicinogenic was isolated. The three drug-resistance determinants were transferred singly, in pairs or en bloc to sensitive Esch
Autor:
Y A, Chabbert
Publikováno v:
The Journal of antimicrobial chemotherapy. 22
This review of spiramycin activity in vitro is based mainly on early studies. The MICs of spiramycin for common pathogenic bacteria such as staphylococci, streptococci and pneumococci are higher than those of erythromycin. Conversely, in experimental